A-round with leading investors Secured
22 December 2021
Sunrise is proud to announce its A-round of €6,5M led by top-tier digital health investors in Europe, Kurma Partners, VIVES Inter-University Fund, NAMUR INVEST, the European Innovation Council and BioWin - The Health Cluster of Wallonia.
"Thanks to the success of this fundraising, which brings together leading investors, Sunrise has reached a new stage in its development. It confirms the investors' confidence in the team's ability to accelerate the company's technological development, to continue to innovate and bring to market easier to use, lighter and more comfortable technologies for sleep apnea patients worldwide".
Laurent Martinot, CEO of Sunrise.
"We are pleased to support Sunrise. The rigor and commitment of its teams made us believe in their vision very early on. Sleep-disordered breathing is a real public health issue: it is one of the main causes of serious illnesses throughout the world. Sunrise is building the future of sleep diagnosis, to make it accessible to the largest number of people and to help doctors deal with the increase in the number of sleep tests linked to growing awareness of this serious disease and the significant prevalence of sleep disorders in the population".
Philippe Peltier, Partner at Kurma Partners
"For decades, the St. Elisabeth pulmonology center (UCLouvain) has been engaged in research on sleep disorders and has been highlighting these public health issues. Meeting this unmet medical need for patients is the mission of Sunrise. This investment illustrates our desire to promote and accelerate scientific breakthroughs in this complex field by bringing together the strengths of academia, industry and public authorities".
Philippe Durieux, CEO Sopartec – VIVES Funds
Read the press release: https://lnkd.in/dfiSkGMM
To support its growth, Sunrise is hiring. Check our careers page.